CJC-1295 vs Epithalon + Follistatin Stack

Overview

CJC-1295 and Epithalon + Follistatin Stack are both performance & growth peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares CJC-1295 and Epithalon + Follistatin Stack across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. CJC-1295 is categorised under Performance & Growth, while Epithalon + Follistatin Stack falls under Performance & Growth. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. CJC-1295: not FDA-approved; treated as a research compound. Epithalon + Follistatin Stack: not FDA-approved; compounding permitted with a prescription as of April 2026.

Dosing. CJC-1295 is typically dosed at 1-2 mg (weekly). Epithalon + Follistatin Stack is typically dosed at Protocol varies (cycled).

Can you stack them?

Some protocols combine peptides, but stacking CJC-1295 and Epithalon + Follistatin Stack has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between CJC-1295 and Epithalon + Follistatin Stack?

CJC-1295 and Epithalon + Follistatin Stack are both performance & growth peptides, but they differ in mechanism, dosing, and regulatory status. CJC-1295 is not FDA-approved; generally classified as a research compound, whereas Epithalon + Follistatin Stack is not FDA-approved; compounding permitted with a prescription (as of April 2026).

What is CJC-1295 used for?

Growth hormone, muscle mass, fat loss.

What is Epithalon + Follistatin Stack used for?

Anti-aging performance combo.

Can you take CJC-1295 and Epithalon + Follistatin Stack together?

Some users combine peptides within a single protocol, but stacking CJC-1295 and Epithalon + Follistatin Stack has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is CJC-1295 or Epithalon + Follistatin Stack FDA-approved?

CJC-1295 is not FDA-approved; generally classified as a research compound. Epithalon + Follistatin Stack is not FDA-approved; compounding permitted with a prescription (as of April 2026).